These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32791705)

  • 1. Comparison of clinicopathologic profiles and prognosis of gastric cancer in the upper, middle and lower third of the stomach: A retrospective cohort study.
    Ma X; Zhang C; Wang C; Miao W; Zhou W; An J; Qiao W; Li M; Lai M; Yu P
    Medicine (Baltimore); 2020 Jul; 99(30):e21261. PubMed ID: 32791705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic characteristics in patients with upper third gastric cancer following radical surgical treatment: A retrospective cohort study.
    Ma X; Zhou W; Wang C; Miao W; Liu N; Wang S; Guan S
    Medicine (Baltimore); 2018 Nov; 97(45):e13017. PubMed ID: 30407293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor size as a prognostic factor in patients with advanced gastric cancer in the lower third of the stomach.
    Wang HM; Huang CM; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Lu J
    World J Gastroenterol; 2012 Oct; 18(38):5470-5. PubMed ID: 23082065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic factors of lymph node-negative metastasis gastric cancer].
    Sun D; Xu H; Huang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of lymph node metastasis correlation with prognosis in patients with T2 gastric cancer.
    Liu X; Long Z; Cai H; Huang H; Shi Y; Wang Y
    PLoS One; 2014; 9(8):e105112. PubMed ID: 25136920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic profiles and prognosis of gastric carcinomas from the cardia, fundus/body and antrum.
    Pinto-De-Sousa J; David L; Seixas M; Pimenta A
    Dig Surg; 2001; 18(2):102-10. PubMed ID: 11351154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
    Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
    World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is tumor size a prognostic indicator for gastric carcinoma?
    Yokota T; Ishiyama S; Saito T; Teshima S; Yamada Y; Iwamoto K; Takahashi M; Murata K; Yamauchi H
    Anticancer Res; 2002; 22(6B):3673-7. PubMed ID: 12552975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and prognostic impact of prophylactic laparoscopic superior mesenteric vein (No. 14v) lymph node dissection for lower-third gastric cancer: a propensity score-matched case-control study.
    Chen QY; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Huang CM
    Surg Endosc; 2018 Mar; 32(3):1495-1505. PubMed ID: 28916893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of the circadian clock gene NPAS2 is associated with progression and poor prognosis of gastric cancer: A single-center study.
    Cao XM; Kang WD; Xia TH; Yuan SB; Guo CA; Wang WJ; Liu HB
    World J Gastroenterol; 2023 Jun; 29(23):3645-3657. PubMed ID: 37398880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
    Song S; Liu H; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Node-extranodal soft tissue stage based on extranodal metastasis is associated with poor prognosis of patients with gastric cancer.
    Jiang N; Deng JY; Ding XW; Ke B; Liu N; Liang H
    J Surg Res; 2014 Nov; 192(1):90-7. PubMed ID: 24953988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node metastasis as a significant prognostic factor in gastric cancer: a multiple logistic regression analysis.
    Yokota T; Ishiyama S; Saito T; Teshima S; Narushima Y; Murata K; Iwamoto K; Yashima R; Yamauchi H; Kikuchi S
    Scand J Gastroenterol; 2004 Apr; 39(4):380-4. PubMed ID: 15125471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node metastasis as a significant prognostic factor in early gastric cancer: analysis of 1,136 early gastric cancers.
    Kim JP; Hur YS; Yang HK
    Ann Surg Oncol; 1995 Jul; 2(4):308-13. PubMed ID: 7552619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can the neutrophil-lymphocyte ratio and platelet-lymphocyte ratio be beneficial in predicting lymph node metastasis and promising prognostic markers of gastric cancer patients? Tumor maker retrospective study.
    Zhang LX; Wei ZJ; Xu AM; Zang JH
    Int J Surg; 2018 Aug; 56():320-327. PubMed ID: 29969732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant prognostic factors in patients with early gastric cancer.
    Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
    Int Surg; 2000; 85(4):286-90. PubMed ID: 11589593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological features associated with lymph node metastasis in early gastric cancer: analysis of a single-institution experience in China.
    Shen L; Huang Y; Sun M; Xu H; Wei W; Wu W
    Can J Gastroenterol; 2009 May; 23(5):353-6. PubMed ID: 19440566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
    Guo J; Zu G; Zhou T; Xing J; Wang Z
    Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors of advanced gastric carcinoma without serosal invasion (pT2 gastric carcinoma).
    Isozaki H; Fujii K; Nomura E; Mabuchi H; Nishiguchi K; Hara H; Tanigawa N
    Hepatogastroenterology; 1999; 46(28):2669-72. PubMed ID: 10522062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.